|
Issue |
Title |
|
Vol 10, No 3 (2013) |
Коррекция дислипидемий при сопутствующей артериальной гипертонии с позиций обновленной парадигмы сердечно-сосудистого риска |
Abstract
|
|
|
Vol 10, No 3 (2013) |
Влияние разных схем антигипертензивной терапии с достижением целевых значений артериального давления на состояние функции почек и внутрипочечное сосудистое сопротивление у больных сахарным диабетом типа 2 |
Abstract
|
, , |
|
Vol 10, No 3 (2013) |
Изучение когнитивных функций мозга у больных артериальной гипертонией с наличием или отсутствием метаболического синдрома |
Abstract
|
, , |
|
Vol 11, No 1 (2014) |
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components |
Abstract
PDF (Rus)
|
Yu. V. Zhernakova, G. Kh. Sharipova, I. E. Chazova |
|
Vol 11, No 2 (2014) |
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders |
Abstract
PDF (Rus)
|
Yu. V. Zhernakova, I. E. Chazova |
|
Vol 11, No 2 (2014) |
Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia |
Abstract
PDF (Rus)
|
M. Yu. Zubareva, P. P. Malyshev, T. A. Rozhkova, V. V. Kuharchuk |
|
Vol 11, No 2 (2014) |
The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management |
Abstract
PDF (Rus)
|
V. N. Shishkova |
|
Vol 11, No 3 (2014) |
Phylogentic theory of pathology. Common phylogenetic features in the pathogenesis of essential arterial hyperntesion and insulin resistance syndrome |
Abstract
PDF (Rus)
|
V. N. Titov |
|
Vol 11, No 4 (2014) |
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders |
Abstract
|
Yu. V. Zhernakov, I. Ye. Chazova |
|
Vol 13, No 2 (2016) |
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs |
Abstract
PDF (Rus)
|
O. D. Ostroumova, A. A. Zykova, M. L. Maksimov |
|
Vol 10, No 2 (2013) |
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome |
Abstract
|
S. V. Nedogoda, A. S. Salasyuk, T. A. Chalyabi, I. N. Barykina, D. A. Pocheptsov, A. A. Ledyaeva, V. V. Tsoma, E. V. Chumachek |
|
Vol 13, No 3 (2016) |
Control of cardiovascular risk in patients with diabetes |
Abstract
PDF (Rus)
|
Yu. V. Zhernakova, I. E. Chazova |
|
Vol 10, No 2 (2013) |
Use of diuretics in hypertensive patients with metabolic disturbances |
Abstract
|
, |
|
Vol 13, No 3 (2016) |
Ethnogenetic aspects of obesity and disorders of carbohydrate metabolism as a risk factor of arterial hypertension |
Abstract
PDF (Rus)
|
T. A. Mulerova, D. P. Tsygankova, E. N. Voropaeva, V. N. Maksimov, M. Yu. Ogarkov |
|
Vol 10, No 2 (2013) |
Additional possibilities of antihypertensive therapy for metabolic syndrome |
Abstract
|
O. A. Kislyak, M. V. Pokhilchenko |
|
Vol 13, No 4 (2016) |
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome |
Abstract
PDF (Rus)
|
N. V. Blinova, Yu. V. Zhernakova, I. E. Chazova, E. V. Oshchepkova |
|
Vol 10, No 2 (2013) |
Subclinical vessel lesion in normotensive patients with abdominal obesity: focus on arterial stiffness |
Abstract
|
M. A. Druzhilov, V. V. Otmakhov, Yu. E. Beteleva, V. A. Korneva, T. Yu. Kuznetsova |
|
Vol 14, No 1 (2017) |
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients |
Abstract
PDF (Rus)
|
Yu. V. Zhernakova, T. V. Martyniuk, O. A. Arkhipova, M. O. Azimova, A. N. Rogoza, I. E. Chazova |
|
Vol 10, No 2 (2013) |
Efficacy of irbesartan in arterial hypertension and metabolic syndrome |
Abstract
|
O. D. Ostroumova, A. A. Zykova, T. A. Polosova, O. V. Bondarets |
|
Vol 16, No 4 (2019) |
Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity |
Abstract
PDF (Rus)
|
E. A. Zheleznova, J. V. Zhernakova, O. A. Pogorelova, M. I. Tripoten, N. V. Blinova, M. A. Shariya, M. O. Azimova, S. B. Gorieva, A. V. Maslov, T. V. Balakhonova, I. E. Chazova |
|
Vol 10, No 3 (2013) |
Применение диуретиков у больных артериальной гипертонией с метаболическими нарушениями |
Abstract
|
, |
|
1 - 21 of 21 Items |
|